Type 1 diabetes through the life span: a position statement of the American Diabetes Association - PubMed (original) (raw)

Type 1 diabetes through the life span: a position statement of the American Diabetes Association

Jane L Chiang et al. Diabetes Care. 2014 Jul.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

The percentage of antibody-positive subjects is affected by the duration of type 1 diabetes for GADA (A) and IA2A (B). Given an increase in the scatter (due to lower numbers of subjects), the x-axis is truncated at a duration of 30 years. Reproduced with permission from Tridgell et al. (16).

Similar articles

Cited by

References

    1. Prime Group for JDRF Type 1 Diabetes, 2010 JDRF, 2011
    1. Lawrence JM, Imperatore G, Pettitt DJ, et al. SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in U.S. youth by type , race/ethnicity, and age, 2008–2009. Diabetes 2014;63(Suppl. 1):A407.
    1. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777–1782 - PubMed
    1. Pettitt DJ, Talton J, Dabelea D, et al. SEARCH for Diabetes in Youth Study Group Prevalence of diabetes in U.S. youth in 2009: the SEARCH for Diabetes in Youth study. Diabetes Care 2014;37:402–408 - PMC - PubMed
    1. Hawa MI, Kolb H, Schloot N, et al. Action LADA consortium Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care 2013;36:908–913 - PMC - PubMed

MeSH terms

LinkOut - more resources